Institutional investors purchased a net $989.0 thousand shares of GHDX during the quarter ended December 2014 and now own 94.45% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAKER BROS. ADVISORS LP Bought 209.0 Thousand shares of Genomic Health Inc
STONEBRIDGE CAPITAL MANAGEMENT, ... Bought 1.8 Thousand shares of Genomic Health Inc
STATE STREET GLOBAL ADVISORS LTD... Bought 104.00 shares of Genomic Health Inc